Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Significant Decline in Short Interest

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the target of a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 30,788 shares, a decline of 33.1% from the November 30th total of 45,995 shares. Based on an average trading volume of 22,913 shares, the short-interest ratio is presently 1.3 days. Currently, 0.1% of the shares of the company are sold short. Currently, 0.1% of the shares of the company are sold short. Based on an average trading volume of 22,913 shares, the short-interest ratio is presently 1.3 days.

Institutional Trading of Zhengye Biotechnology

A number of hedge funds have recently added to or reduced their stakes in ZYBT. Citadel Advisors LLC acquired a new stake in Zhengye Biotechnology during the third quarter valued at $31,000. Millennium Management LLC acquired a new stake in shares of Zhengye Biotechnology during the 3rd quarter valued at about $38,000. WINTON GROUP Ltd acquired a new stake in shares of Zhengye Biotechnology during the 3rd quarter valued at about $56,000. Geode Capital Management LLC purchased a new position in shares of Zhengye Biotechnology in the 2nd quarter valued at about $174,000. Finally, Invesco Ltd. acquired a new position in Zhengye Biotechnology in the 2nd quarter worth about $220,000.

Zhengye Biotechnology Stock Down 5.8%

Shares of ZYBT stock opened at $1.13 on Wednesday. Zhengye Biotechnology has a twelve month low of $1.11 and a twelve month high of $14.30. The stock has a 50 day moving average of $2.07 and a 200 day moving average of $4.83. The company has a current ratio of 1.49, a quick ratio of 1.10 and a debt-to-equity ratio of 0.01.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Zhengye Biotechnology in a research note on Tuesday, October 14th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.